Endo International plc announced that clinical data from a Phase III investigational study of collagenase clostridium histolyticum (CCH) for the...
Top-line results were announced by Pfizer of a double-blind, Phase III study evaluating pregabalin controlled-release (CR) formulation in patients with...
Ocular Therapeutix has announced topline efficacy results from a Phase III clinical trial to evaluate the safety and efficacy of...
Collegium Pharmaceutical has announced the publication of an analysis of the duration of effect of Xtampza ER (oxycodone extended-release capsules)...